Co-Diagnostics, Inc. (CODX)
USD 0.32
(-9.78%)
USD 0.32
(-9.78%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 6.81 Million USD | -97.1% |
| 2022 | 34.21 Million USD | -65.04% |
| 2021 | 97.88 Million USD | 31.3% |
| 2020 | 74.55 Million USD | 34579.9% |
| 2019 | 214.97 Thousand USD | 438.63% |
| 2018 | 39.91 Thousand USD | 420.9% |
| 2017 | 7662.00 USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 10 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 161.1 Thousand USD | -36.26% |
| 2024 Q1 | 252.74 Thousand USD | -92.89% |
| 2023 FY | 991.47 Thousand USD | -97.1% |
| 2023 Q1 | 601.95 Thousand USD | -57.05% |
| 2023 Q2 | 197.8 Thousand USD | -67.14% |
| 2023 Q3 | 2.45 Million USD | 1142.18% |
| 2023 Q4 | 3.55 Million USD | 44.69% |
| 2022 Q2 | 5.02 Million USD | -77.87% |
| 2022 FY | 34.21 Million USD | -65.04% |
| 2022 Q4 | 1.4 Million USD | -72.49% |
| 2022 Q3 | 5.09 Million USD | 1.42% |
| 2022 Q1 | 22.69 Million USD | 11.26% |
| 2021 Q1 | 20.02 Million USD | -26.23% |
| 2021 FY | 97.88 Million USD | 31.3% |
| 2021 Q4 | 20.4 Million USD | -32.22% |
| 2021 Q3 | 30.1 Million USD | 10.03% |
| 2021 Q2 | 27.35 Million USD | 36.62% |
| 2020 Q3 | 21.81 Million USD | -9.24% |
| 2020 FY | 74.55 Million USD | 34579.9% |
| 2020 Q4 | 27.14 Million USD | 24.41% |
| 2020 Q2 | 24.04 Million USD | 1452.46% |
| 2020 Q1 | 1.54 Million USD | 1326.35% |
| 2019 Q1 | 3400.00 USD | -68.59% |
| 2019 Q4 | 108.56 Thousand USD | 162.02% |
| 2019 Q2 | 61.57 Thousand USD | 1711.0% |
| 2019 Q3 | 41.43 Thousand USD | -32.71% |
| 2019 FY | 214.97 Thousand USD | 438.63% |
| 2018 Q3 | 9696.00 USD | 0.0% |
| 2018 FY | 39.91 Thousand USD | 420.9% |
| 2018 Q1 | 9696.00 USD | 273.21% |
| 2018 Q2 | 9696.00 USD | 0.0% |
| 2018 Q4 | 10.82 Thousand USD | 11.62% |
| 2017 Q4 | 2598.00 USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | 7662.00 USD | 0.0% |
| 2017 Q3 | 2598.00 USD | 5.35% |
| 2017 Q2 | 2466.00 USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2016 FY | - USD | -100.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 FY | 10 Thousand USD | 0.0% |
| 2015 Q4 | 10 Thousand USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | 4.913% |
| Cerus Corporation | 156.36 Million USD | 95.644% |
| OrthoPediatrics Corp. | 148.73 Million USD | 95.42% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -603.21% |
| Talis Biomedical Corporation | 412 Thousand USD | -1553.407% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 50.641% |
| Inogen, Inc. | 315.66 Million USD | 97.842% |
| Spectral AI, Inc. | 18.05 Million USD | 62.273% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 31.226% |
| CVRx, Inc. | 39.29 Million USD | 82.664% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -957.77% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.088% |
| Venus Concept Inc. | 76.35 Million USD | 91.078% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 43.511% |
| Bioventus Inc. | 512.34 Million USD | 98.67% |
| BrainsWay Ltd. | 31.78 Million USD | 78.568% |
| Envoy Medical, Inc. | 316 Thousand USD | -2055.708% |
| electroCore, Inc. | 16.03 Million USD | 57.504% |
| IceCure Medical Ltd | 3.22 Million USD | -110.964% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -180.562% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -1766.317% |
| MaxCyte, Inc. | 41.28 Million USD | 83.501% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -248.899% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -6050.935% |
| PAVmed Inc | 2.45 Million USD | -177.816% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 69.75% |
| RxSight, Inc. | 89.07 Million USD | 92.353% |
| Sight Sciences, Inc. | 81.05 Million USD | 91.596% |
| SI-BONE, Inc. | 138.88 Million USD | 95.095% |
| TELA Bio, Inc. | 58.45 Million USD | 88.346% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 63.2% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 96.359% |
| LivaNova PLC | 1.15 Billion USD | 99.409% |
| 908 Devices Inc. | 50.22 Million USD | 86.438% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 98.587% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -8741.75% |
| NeuroPace, Inc. | 65.42 Million USD | 89.587% |
| LENSAR, Inc. | 42.16 Million USD | 83.844% |
| Apyx Medical Corporation | 52.34 Million USD | 86.987% |
| Cutera, Inc. | 212.36 Million USD | 96.792% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 79.579% |
| BioSig Technologies, Inc. | 18 Thousand USD | -37744.656% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 95.913% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 71.563% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.558% |
| Axonics, Inc. | 366.37 Million USD | 98.141% |
| Outset Medical, Inc. | 130.37 Million USD | 94.775% |
| IRIDEX Corporation | 51.86 Million USD | 86.867% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 94.998% |
| IRadimed Corporation | 65.56 Million USD | 89.61% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -479.255% |
| INVO Bioscience, Inc. | 3.02 Million USD | -125.521% |
| Telesis Bio, Inc. | 27.5 Million USD | 75.237% |
| Viemed Healthcare, Inc. | 183 Million USD | 96.278% |
| Varex Imaging Corporation | 811 Million USD | 99.16% |
| Quipt Home Medical Corp. | 221.74 Million USD | 96.928% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 90.081% |
| Dynatronics Corporation | 32.53 Million USD | 79.062% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 21.502% |
| Semler Scientific, Inc. | 68.18 Million USD | 90.009% |
| InMode Ltd. | 492.04 Million USD | 98.616% |
| Bruker Corporation | 2.96 Billion USD | 99.77% |
| Cytosorbents Corporation | 36.34 Million USD | 81.26% |
| DexCom, Inc. | 3.62 Billion USD | 99.812% |
| Align Technology, Inc. | 3.86 Billion USD | 99.824% |
| Viveve Medical, Inc. | 6.42 Million USD | -6.007% |
| ZimVie Inc. | 457.43 Million USD | 98.511% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 96.471% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -6050.935% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.089% |
| Profound Medical Corp. | 7.33 Million USD | 7.079% |
| Insulet Corporation | 1.69 Billion USD | 99.599% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 94.597% |
| iCAD, Inc. | 17.31 Million USD | 60.665% |
| Nuwellis, Inc. | 8.86 Million USD | 23.149% |
| Biotricity, Inc. | 12.06 Million USD | 43.531% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 98.617% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -9.783% |
| PAVmed Inc. | 2.45 Million USD | -177.816% |
| BIOLASE, Inc. | 49.16 Million USD | 86.144% |
| Beyond Air, Inc. | 1.15 Million USD | -487.751% |
| FONAR Corporation | 102.88 Million USD | 93.379% |
| AxoGen, Inc. | 159.01 Million USD | 95.716% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 97.518% |
| Inari Medical, Inc. | 493.63 Million USD | 98.62% |
| UFP Technologies, Inc. | 400.07 Million USD | 98.297% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -36523.86% |
| Tenon Medical, Inc. | 2.92 Million USD | -132.652% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.787% |
| Sintx Technologies, Inc. | 2.62 Million USD | -159.309% |
| NanoVibronix, Inc. | 2.28 Million USD | -198.381% |
| Quanterix Corporation | 122.36 Million USD | 94.433% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 72.088% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 96.603% |
| TransMedics Group, Inc. | 241.62 Million USD | 97.181% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 50.83% |
| NeuroMetrix, Inc. | 5.9 Million USD | -15.43% |
| Hyperfine, Inc. | 11.03 Million USD | 38.252% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 95.875% |
| Biomerica, Inc. | 5.41 Million USD | -25.799% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 86.527% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 96.154% |